Rhumbline Advisers Omeros Corp Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Omeros Corp stock. As of the latest transaction made, Rhumbline Advisers holds 98,825 shares of OMER stock, worth $436,806. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98,825
Previous 107,597
8.15%
Holding current value
$436,806
Previous $884,000
66.52%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding OMER
# of Institutions
142Shares Held
29.8MCall Options Held
376KPut Options Held
1.21M-
Black Rock Inc. New York, NY4.1MShares$18.1 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY3.98MShares$17.6 Million0.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.28MShares$14.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.65MShares$7.28 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.52MShares$6.73 Million0.0% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $277M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...